Biocellvia is a team of biologists and computer scientists who support you in the development of your preclinical and clinical projects using image analysis tools developed inhouse and specific to each pathology.
Biocellvia was created in September 2011 by Prof. Yvon Julé and his son Olivier. As early as 2011, they made the following observation: throughout the development cycle of a drug, scientists work from subjective data, in particular for the evaluation of the effectiveness of molecules, which has the direct consequence a high failure rate in the clinical phase.
Why so many failures?
Many tasks remain manual and depend on the observer, with the biases that this entails.
In order to address this major problem, Biocellvia has developed tests using digital images of histological sections to better assess drug candidates specifically for each pathology. These tests provide scientists with very accurate, precise and reliable data, ideal for informed decision-making.
Building on Professor Yvon Julé’s academic career, renowned universities and researchers have quickly adopted this technology, which allows them to explain and discover new mechanisms, to better understand the evolution of a disease based on extremely robust data, which was not possible with the pathologist’s visual assessment.
What is the next step ?
Biocellvia first worked on in vivo models in preclinical. We are now also working on clinical trials where our technology can better characterize the disease, whether that is to determine the eligibility of patients to participate in a clinical trial or to assess disease progression.